News & Updates

Welldoc Achieves Significant Digital Health Milestone by Securing Its 10th Patent for Its BlueStar Digital Therapeutic

January 7, 2019

Colum­bia, MD – Jan­u­ary 7, 2019Well­doc®, a lead­ing dig­i­tal health com­pa­ny, announced today that it has secured a tech­nol­o­gy patent (based on U.S. Patent Appli­ca­tion No. 15/923,010) from the Unit­ed States Patent and Trade­mark Office for the Soft­ware Engine Tech­nol­o­gy that pow­ers its BlueS­tar® dig­i­tal ther­a­peu­tic.

The award­ing of this tenth tech­nol­o­gy patent to Well­doc is a val­i­da­tion of our inno­va­tion in dig­i­tal health and our delib­er­ate strat­e­gy to cre­ate a sim­ple, sus­tain­able and scal­able solu­tion for all peo­ple liv­ing with dia­betes,” said Well­doc Pres­i­dent and CEO Kevin McRaith. “We are trail­blaz­ers who have paved the way for oth­er dig­i­tal health com­pa­nies seek­ing both patent and reg­u­la­to­ry approval in the mar­ket­place.”

Welldoc’s ground­break­ing tech­nol­o­gy is guid­ing indi­vid­u­als through the com­plex jour­ney of liv­ing with chron­ic dis­ease, with the goal of help­ing indi­vid­u­als improve how they self-man­age their con­di­tions to sig­nif­i­cant­ly improve their clin­i­cal out­comes and help dri­ve cost sav­ings. The Company’s inno­v­a­tive approach lever­ages mobile tech­nol­o­gy, arti­fi­cial intel­li­gence, the Inter­net of Things (IoT) devices, and pre­ci­sion algo­rithms — dri­ven by its patent­ed soft­ware engine — to facil­i­tate sig­nif­i­cant health out­comes. Addi­tion­al­ly, its dig­i­tal ther­a­peu­tic solu­tions con­nect indi­vid­u­als liv­ing with dia­betes to their own health­care team for opti­mal com­mu­ni­ca­tion and ongo­ing sup­port.

About Well­doc®

Well­doc® is a lead­ing dig­i­tal ther­a­peu­tic com­pa­ny rev­o­lu­tion­iz­ing chron­ic dis­ease man­age­ment to help trans­form lives. The Company’s ground­break­ing tech­nol­o­gy helps guide indi­vid­u­als through the com­pli­cat­ed jour­ney of liv­ing with chron­ic dis­eases, with a goal of help­ing them self-man­age their con­di­tions, while con­nect­ing them to their own health­care team. By uti­liz­ing Welldoc’s dig­i­tal ther­a­peu­tic solu­tions, pay­ers, employ­ers and health­care sys­tems can stream­line their resources by focus­ing on a dig­i­tal health solu­tion to help bet­ter man­age their pop­u­la­tions liv­ing with mul­ti­ple and cost­ly chron­ic dis­eases. Well­doc is based on a life sci­ence busi­ness model—having con­duct­ed mul­ti­ple ran­dom­ized clin­i­cal tri­als result­ing in more than 39 peer-reviewed pub­li­ca­tions. IBM Wat­son Health™ con­duct­ed an inno­v­a­tive eco­nom­ic analy­sis for Well­doc using the Mar­ketScan® Com­mer­cial Claims and Encoun­ters Data­base and the Mar­ketScan® Medicare Sup­ple­men­tal and Coor­di­na­tion of Ben­e­fits Data­base demon­strat­ing an oppor­tu­ni­ty to save a range of $254 to $271 per user per month with the use of the flag­ship BlueS­tar® dig­i­tal ther­a­peu­tic. Well­doc has a sol­id foun­da­tion in the devel­op­ment of solu­tions for the man­age­ment of dia­betes and is rapid­ly cre­at­ing oth­er chron­ic dis­ease solu­tions.  For more infor­ma­tion, vis­it www.welldoc.com.